Benefits & Rewards Benefits & Rewards We invest in our people so they will stay and grow with us. We offer benefits such as rewards and development opportunities to help retain employees.
Algorithms to battle heartworm disease Algorithms to battle heartworm disease Partnership with the University of Melbourne uses AI to develop new veterinary solutions for pets
FDA approval NexGard PLUS for dogs FDA approval NexGard PLUS for dogs Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS - A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites
Ukraine Help: The heroes of Mainz-Finthen Ukraine Help: The heroes of Mainz-Finthen Travis Kelley helps Olena and Wasyl flee from Ukraine. This is the record of a dramatic and emotional rescue operation.
Solid Fundations | Bioxcellence | Boehringer Ingelheim Solid Fundations | Bioxcellence | Boehringer Ingelheim Discover BioXcellence's innovative biopharmaceutical contract manufacturing services, built on a proven track record & solid foundation. Explore now!
Our people Our people Ambition. Passion. Integrity. Commitment. Empathy. Individuality. We expect these qualities at all levels.
2021 PRRS Research Award winners announced 2021 PRRS Research Award winners announced The 2021 European PRRS Research Award winners announced
Partnership Boehringer Ingelheim Lifebit health data Partnership Boehringer Ingelheim Lifebit health data Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
Siva Thotapalli Siva Thotapalli My career challenge at Boehringer Ingelheim by Siva Thotapalli. Read it now!
preventive care cat veterinarian preventive care cat veterinarian What can we all, cat owners or veterinarians, do to promote cat health? Click to find out!
Boehringer expands cancer research at Vienna site Boehringer expands cancer research at Vienna site Boehringer Ingelheim expands cancer research at its Vienna site
Blue internal teat sealant now in dairy mastitis portfolio Blue internal teat sealant now in dairy mastitis portfolio Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio
Partnering pet therapeutics Partnering pet therapeutics Learn more about our research focus and our most recent partnerships regarding pet therapeutics.
Lung Cancer Lung Cancer Find out more about lung cancer, the second most common cancer worldwide, that claims more lives each year than any other type.
real-world-benefit-shown-in-T2D-treatment real-world-benefit-shown-in-T2D-treatment Real-world evidence study shows type 2 diabetes treatment reduced risk of cardiovascular events and hospitalization for heart failure
Boehringer upgrade in Access to Medicine Health Ranking Boehringer upgrade in Access to Medicine Health Ranking Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking
Rethinking mental health care Rethinking mental health care Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
Ethical Business Practices Ethical Business Practices Suppliers shall conduct their business in an ethical manner and act with integrity.
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Green Chemistry Green Chemistry Green Chemistry is critical for us as it balance the long-term sustainability of business, society, and the environment.
Global language learning platform for our people Global language learning platform for our people One global learning platform for languages, countless opportunities to grow your career
Mareks Disease Poultry Chicken Mareks Disease Poultry Chicken Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems.
Our-position Our-position Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial